Our data showed that HOTAIRM1, post-transcriptionally stabilized by METTL3, bound to IGFBP2, suggesting that HOTAIRM1 promotes VM formation in glioma via up-regulating IGFBP2 expression, providing a theoretical basis for new glioma treatment methods. The gene discussed is METTL3; the disease is central nervous system cancer.